Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RXI 109 for effectiveness and safety in hypertrophic scar patients undergoing scar revision; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Drugs mentioned

• RXI-109 (RXI-109)

Snippet

Sponsor: RXi Pharmaceuticals, Corp. | Conditions: Hypertrophic Scar | Phase 2 | Status: COMPLETED